Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
By Dajana Domik
When patients exhibit symptoms common to more than one disease or invading pathogen it is useful to have a universal biomarker that can help you narrow down the potential causes, monitor progress of an ongoing condition, and give you...
By Roberta Veneroni
In the “new normal” post COVID-19, how can genomics labs be better prepared to respond quickly to the unexpected? How can they deliver reliable and insightful genetic sequencing results faster and more efficiently? What is the...
By David Wold
The global COVID-19 pandemic is putting unprecedented pressure on laboratories to meet demand for accurate, large-scale, high-throughput testing. In such extreme circumstances, conserving samples and minimizing risk of contamination is...
By Oliver Schmidt
HMGB1 is a key mediator in the immune response to SARS-CoV-2, and increased levels can be an important indicator for COVID-19 understanding and its prognosis. In this final piece in our series, we look at the performance of Tecan’s...
By Oliver Schmidt
In the first article in this series, we looked at how HMGB1 has taken an increasingly important position as a key mediator in the immune response, playing a major role in many diseases, from cancer to coronavirus. There is now...
By Oliver Schmidt
How the human body deals with infection depends on an individual’s immune response. When looking at the body’s response to SARS-CoV-2, the state of the immune system has a crucial impact on the clinical outcome. For example, HMGB1...
By Dr Beatrice Marg-Haufe
The COVID-19 pandemic has forced everyone to look at laboratory routines to see if they are really pandemic proof. For example, the explosive demand for high throughput genomic analysis often creates pressures upstream to...
By David Wold
Designing and manufacturing lab instruments that include automated liquid handling is challenging at the best of times, but in the face of increased demand for faster testing, it’s even more critical to select the right partner and...
By Joe Rotter
How do you prepare for the unexpected? The COVID-19 pandemic has brought to light how challenging it is for labs and production facilities to scale up quickly in times of need. The sudden surge in demand for laboratory solutions at the...